Summitry LLC Acquires 492 Shares of Balchem Co. (NASDAQ:BCPC)

Summitry LLC increased its stake in Balchem Co. (NASDAQ:BCPC) by 41.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,687 shares of the basic materials company’s stock after acquiring an additional 492 shares during the quarter. Summitry LLC’s holdings in Balchem were worth $275,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Westside Investment Management Inc. acquired a new position in shares of Balchem during the third quarter valued at about $27,000. R Squared Ltd acquired a new position in Balchem during the 4th quarter worth approximately $29,000. Wilmington Savings Fund Society FSB acquired a new stake in Balchem in the third quarter valued at approximately $35,000. Venturi Wealth Management LLC bought a new stake in shares of Balchem during the fourth quarter valued at approximately $95,000. Finally, Smartleaf Asset Management LLC raised its position in shares of Balchem by 230.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock worth $106,000 after purchasing an additional 450 shares during the period. Institutional investors and hedge funds own 87.91% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Sidoti upgraded shares of Balchem to a “hold” rating in a research note on Tuesday, February 25th. HC Wainwright restated a “buy” rating and issued a $190.00 target price on shares of Balchem in a report on Monday, February 24th. Finally, StockNews.com downgraded Balchem from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th.

Balchem Stock Performance

NASDAQ BCPC opened at $163.33 on Wednesday. The company has a fifty day moving average price of $164.97 and a 200-day moving average price of $169.31. The firm has a market cap of $5.31 billion, a price-to-earnings ratio of 41.56, a PEG ratio of 4.41 and a beta of 0.63. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. Balchem Co. has a 1 year low of $137.69 and a 1 year high of $186.03.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm had revenue of $240.00 million during the quarter, compared to analysts’ expectations of $239.96 million. As a group, equities research analysts predict that Balchem Co. will post 4.64 EPS for the current fiscal year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.